NO891501L - Hetera-alifatiske karboksamider. - Google Patents

Hetera-alifatiske karboksamider.

Info

Publication number
NO891501L
NO891501L NO89891501A NO891501A NO891501L NO 891501 L NO891501 L NO 891501L NO 89891501 A NO89891501 A NO 89891501A NO 891501 A NO891501 A NO 891501A NO 891501 L NO891501 L NO 891501L
Authority
NO
Norway
Prior art keywords
formula
compounds
hetera
carboxamids
alifatic
Prior art date
Application number
NO89891501A
Other languages
English (en)
Norwegian (no)
Other versions
NO891501D0 (no
Inventor
Victor Giulio Matassa
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO891501D0 publication Critical patent/NO891501D0/no
Publication of NO891501L publication Critical patent/NO891501L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO89891501A 1988-04-14 1989-04-12 Hetera-alifatiske karboksamider. NO891501L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18133488A 1988-04-14 1988-04-14

Publications (2)

Publication Number Publication Date
NO891501D0 NO891501D0 (no) 1989-04-12
NO891501L true NO891501L (no) 1989-10-16

Family

ID=22663845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891501A NO891501L (no) 1988-04-14 1989-04-12 Hetera-alifatiske karboksamider.

Country Status (23)

Country Link
EP (1) EP0337766B1 (de)
JP (1) JP2740250B2 (de)
KR (1) KR890016016A (de)
CN (1) CN1037895A (de)
AT (1) ATE86612T1 (de)
AU (1) AU622649B2 (de)
CA (1) CA1334197C (de)
DD (1) DD286581A5 (de)
DE (1) DE68905216T2 (de)
DK (1) DK176089A (de)
ES (1) ES2053983T3 (de)
FI (1) FI891764A7 (de)
GB (1) GB8906032D0 (de)
GR (1) GR3007302T3 (de)
HU (1) HUT54995A (de)
IE (1) IE63209B1 (de)
IL (1) IL89925A0 (de)
MW (1) MW2189A1 (de)
NO (1) NO891501L (de)
NZ (1) NZ228722A (de)
PT (1) PT90269B (de)
ZA (1) ZA892637B (de)
ZM (1) ZM1689A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
ATE122656T1 (de) * 1991-10-25 1995-06-15 Ciba Geigy Ag Verfahren zur herstellung substituierter indole.
EP0539329A1 (de) * 1991-10-25 1993-04-28 Ciba-Geigy Ag Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
CN1092639C (zh) * 1995-01-06 2002-10-16 东丽株式会社 苯稠合杂环衍生物及其用途
GEP20032920B (en) * 1998-02-25 2003-03-25 Genetics Inst Inhibitors of Phospholipase Enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
TW201309670A (zh) 2011-01-25 2013-03-01 Kissei Pharmaceutical 吲哚衍生物或其藥理學上容許之鹽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides

Also Published As

Publication number Publication date
EP0337766B1 (de) 1993-03-10
IE891188L (en) 1989-10-14
FI891764A7 (fi) 1989-10-15
CN1037895A (zh) 1989-12-13
JPH01311063A (ja) 1989-12-15
DD286581A5 (de) 1991-01-31
PT90269B (pt) 1994-07-29
DE68905216T2 (de) 1993-06-17
AU622649B2 (en) 1992-04-16
FI891764A0 (fi) 1989-04-13
HUT54995A (en) 1991-04-29
NO891501D0 (no) 1989-04-12
KR890016016A (ko) 1989-11-28
DE68905216D1 (de) 1993-04-15
NZ228722A (en) 1991-08-27
DK176089D0 (da) 1989-04-12
AU3177089A (en) 1989-10-19
ZA892637B (en) 1989-12-27
JP2740250B2 (ja) 1998-04-15
GR3007302T3 (de) 1993-07-30
DK176089A (da) 1989-10-15
ES2053983T3 (es) 1994-08-01
EP0337766A1 (de) 1989-10-18
GB8906032D0 (en) 1989-04-26
IE63209B1 (en) 1995-04-05
ATE86612T1 (de) 1993-03-15
MW2189A1 (en) 1989-12-13
CA1334197C (en) 1995-01-31
PT90269A (pt) 1989-11-10
IL89925A0 (en) 1989-12-15
ZM1689A1 (en) 1990-01-26

Similar Documents

Publication Publication Date Title
NO941611L (no) Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser
NO955074L (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
NO20052864L (no) Nye hydroksyindoler, deres anvendelse som fosfordiesterase 4 inhibitorer samt fremstilling av forbindelser
NO882608D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
NO964700L (no) Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser
ES554580A0 (es) Procedimiento para preparar derivados de amidoindol y amidoindazol
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
NO922940L (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
DE3836676A1 (de) Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
ES2045420T3 (es) Amidas ciclicas.
DK176089A (da) Hetera-alifatiske carboxamider
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
IE862737L (en) Heterocyclic compounds
NO941977L (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
IE881086L (en) Aliphatic carboxamides
DK527984D0 (da) 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika
NO963655L (no) Nye aminosyrederivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
NO922358L (no) Tert.-butylfenyl-1-amino-4-hydroksybutanderivater, fremgangsmaate ved deres fremstilling og farmasoeytiske preparaterinneholdende forbindelsene
NO971424L (no) Nye heterocyklisk substituerte imidazolo-kinoksalinoner, deres fremstilling og anvendelse
NO961677L (no) Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
SU1731048A3 (ru) Способ получени производных пиперидина или их фармацевтически приемлемых солей
NO940131L (no) Salter av 4-pyrimidinon-derivater for farmasöytisk anvendelse